Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1988 30
1989 92
1990 120
1991 164
1992 203
1993 229
1994 187
1995 207
1996 188
1997 181
1998 161
1999 160
2000 154
2001 177
2002 185
2003 153
2004 168
2005 143
2006 184
2007 169
2008 208
2009 187
2010 195
2011 202
2012 203
2013 171
2014 188
2015 180
2016 164
2017 167
2018 214
2019 116
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

5,126 results
Results by year
Filters applied: . Clear all
Page 1
Dystrophin As a Molecular Shock Absorber.
Le S, Yu M, Hovan L, Zhao Z, Ervasti J, Yan J. Le S, et al. ACS Nano. 2018 Dec 26;12(12):12140-12148. doi: 10.1021/acsnano.8b05721. Epub 2018 Nov 27. ACS Nano. 2018. PMID: 30457830 Free PMC article.
Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy.
Amoasii L, Hildyard JCW, Li H, Sanchez-Ortiz E, Mireault A, Caballero D, Harron R, Stathopoulou TR, Massey C, Shelton JM, Bassel-Duby R, Piercy RJ, Olson EN. Amoasii L, et al. Science. 2018 Oct 5;362(6410):86-91. doi: 10.1126/science.aau1549. Epub 2018 Aug 30. Science. 2018. PMID: 30166439 Free PMC article.
The molecular cross talk of the dystrophin-glycoprotein complex.
Gawor M, Prószyński TJ. Gawor M, et al. Ann N Y Acad Sci. 2018 Jan;1412(1):62-72. doi: 10.1111/nyas.13500. Epub 2017 Oct 25. Ann N Y Acad Sci. 2018. PMID: 29068540 Review.
Eteplirsen treatment for Duchenne muscular dystrophy: Exon skipping and dystrophin production.
Charleston JS, Schnell FJ, Dworzak J, Donoghue C, Lewis S, Chen L, Young GD, Milici AJ, Voss J, DeAlwis U, Wentworth B, Rodino-Klapac LR, Sahenk Z, Frank D, Mendell JR. Charleston JS, et al. Neurology. 2018 Jun 12;90(24):e2146-e2154. doi: 10.1212/WNL.0000000000005680. Epub 2018 May 11. Neurology. 2018. PMID: 29752304 Clinical Trial.
Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy.
Amoasii L, Long C, Li H, Mireault AA, Shelton JM, Sanchez-Ortiz E, McAnally JR, Bhattacharyya S, Schmidt F, Grimm D, Hauschka SD, Bassel-Duby R, Olson EN. Amoasii L, et al. Sci Transl Med. 2017 Nov 29;9(418):eaan8081. doi: 10.1126/scitranslmed.aan8081. Sci Transl Med. 2017. PMID: 29187645 Free PMC article.
Lentiviral vectors can be used for full-length dystrophin gene therapy.
Counsell JR, Asgarian Z, Meng J, Ferrer V, Vink CA, Howe SJ, Waddington SN, Thrasher AJ, Muntoni F, Morgan JE, Danos O. Counsell JR, et al. Sci Rep. 2017 Mar 17;7:44775. doi: 10.1038/srep44775. Sci Rep. 2017. PMID: 28303972 Free PMC article.
5,126 results
Jump to page
Feedback